Colecalciferol and Impaired gastric emptying - a phase IV clinical study of FDA data

Summary:

Impaired gastric emptying is reported only by a few people who take Colecalciferol.

The phase IV clinical study analyzes which people take Colecalciferol and have Impaired gastric emptying. It is created by eHealthMe based on reports of 20,783 people who have side effects while taking Colecalciferol from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

20,783 people reported to have side effects when taking Colecalciferol.
Among them, 4 people (0.02%) have Impaired gastric emptying.

What is Colecalciferol?

Colecalciferol has active ingredients of cholecalciferol. eHealthMe is studying from 20,881 Colecalciferol users for its effectiveness, alternative drugs and more.

What is Impaired gastric emptying?

Impaired gastric emptying is found to be associated with 1,587 drugs and 735 conditions by eHealthMe.

Number of Colecalciferol and Impaired gastric emptying reports submitted per year:

Could Colecalciferol cause Impaired gastric emptying?

Gender of people who have Impaired gastric emptying when taking Colecalciferol *:

female: 33.33 %
male: 66.67 %

Age of people who have Impaired gastric emptying when taking Colecalciferol *:

Common drugs people take besides Colecalciferol *:

Common side effects people have besides Impaired gastric emptying *:

Nausea And Vomiting: 3 people, 75.00%
Ileus Paralytic (obstruction of the intestine due to paralysis of the intestinal muscles): 3 people, 75.00%
Weight Increased: 1 person, 25.00%
Urinary Tract Infection: 1 person, 25.00%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 25.00%
Sinusitis Bacterial (bacterial infection of sinus): 1 person, 25.00%
Kidney Infection: 1 person, 25.00%
Infusion Site Swelling: 1 person, 25.00%
Infusion Site Pruritus (severe itching at infusion site): 1 person, 25.00%
Infusion Site Erythema (reddening of the skin at infusion site): 1 person, 25.00%

Common conditions people have *:

Delusion (a false belief or opinion): 3 people, 75.00%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 2 people, 50.00%
Immunodeficiency Common Variable: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Colecalciferol and have Impaired gastric emptying?

Check whether Impaired gastric emptying is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Impaired gastric emptying and when was it recovered:

Impaired gastric emptying in Colecalciferol

Expand to all the drugs that have ingredients of cholecalciferol:

Impaired gastric emptying and drugs with ingredients of cholecalciferol

Alternative drugs to, pros and cons of Colecalciferol:

Colecalciferol (20,881 reports)

Common Colecalciferol side effects:

Fatigue (feeling of tiredness): 1,482 reports
Diarrhea: 1,309 reports
Breathing difficulty: 1,254 reports
Headache (pain in head): 1,105 reports
Pain: 963 reports

Browse all side effects of Colecalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Impaired gastric emptying treatments and more:

Impaired gastric emptying (10,417 reports)

COVID vaccines that are related to Impaired gastric emptying:

Common drugs associated with Impaired gastric emptying:

How the study uses the data?

The study uses data from the FDA. It is based on cholecalciferol (the active ingredients of Colecalciferol) and Colecalciferol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.